Researchers have made a significant advancement in cancer treatment by engineering cells that can destroy tumors. These cells, which may include "natural killer" cells or CAR T cells, are designed to evade the immune system and target various types of cancer, including pancreatic and breast cancer. The specifics of the breakthrough and its applications are still emerging, with different approaches and technologies being explored.